Rachel Toth, OD - Medicare Optometrist in Auburn Hills, MI

Rachel Toth, OD is a medicare enrolled "Optometrist" provider in Auburn Hills, Michigan. She went to Southern College Of Optometry and graduated in 2020 and has 4 years of diverse experience with area of expertise as Optometry. She is a member of the group practice Jartll Corp and her current practice location is 4151 Baldwin Rd, Auburn Hills, Michigan. You can reach out to her office (for appointments etc.) via phone at (248) 858-2223.

Rachel Toth is licensed to practice in Michigan (license number 4901005436) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1144848839.

Contact Information

Rachel Toth, OD
4151 Baldwin Rd,
Auburn Hills, MI 48326-1225
(248) 858-2223
Not Available



Healthcare Provider's Profile

Full NameRachel Toth
GenderFemale
SpecialityOptometry
Experience4 Years
Location4151 Baldwin Rd, Auburn Hills, Michigan
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Rachel Toth attended and graduated from Southern College Of Optometry in 2020
  NPI Data:
  • NPI Number: 1144848839
  • Provider Enumeration Date: 07/08/2020
  • Last Update Date: 11/16/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 0042635518
  • Enrollment ID: I20200730002122

Medical Identifiers

Medical identifiers for Rachel Toth such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1144848839NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 4901005436 (Michigan)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Jartll Corp32746395968

News Archive

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.

ORT remains underutilized in U.S. prison systems

Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).

Modified stroke drug boosts injury repair in rats with spinal cord damage

Adding a modified stroke drug to stem cells used to treat rats with spinal injury boosted the therapy and motor activity.

Overweight kids at greater risk of school absenteeism

In the first study of how weight may affect school attendance, researchers at the University of Pennsylvania and Temple University have found that overweight children are at greater risk of school absenteeism than their normal-weight peers.

AstraZeneca ChAdOx1 nCoV-19 vaccine does not affect fertility and birth rate outcomes, study says

Researchers from the University of Oxford have recently analyzed pregnancies that have occurred during four ChAdOx1 nCoV-19 clinical trials.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Rachel Toth allows following entities to bill medicare on her behalf.
Provider NameJartll Corp
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1952420267
PECOS PAC ID: 3274639596
Enrollment ID: O20070503000237

News Archive

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.

ORT remains underutilized in U.S. prison systems

Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).

Modified stroke drug boosts injury repair in rats with spinal cord damage

Adding a modified stroke drug to stem cells used to treat rats with spinal injury boosted the therapy and motor activity.

Overweight kids at greater risk of school absenteeism

In the first study of how weight may affect school attendance, researchers at the University of Pennsylvania and Temple University have found that overweight children are at greater risk of school absenteeism than their normal-weight peers.

AstraZeneca ChAdOx1 nCoV-19 vaccine does not affect fertility and birth rate outcomes, study says

Researchers from the University of Oxford have recently analyzed pregnancies that have occurred during four ChAdOx1 nCoV-19 clinical trials.

Read more Medical News

› Verified 3 days ago

Provider NameEyecare Of Livonia Pllc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1578097259
PECOS PAC ID: 1951678291
Enrollment ID: O20170517001245

News Archive

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.

ORT remains underutilized in U.S. prison systems

Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).

Modified stroke drug boosts injury repair in rats with spinal cord damage

Adding a modified stroke drug to stem cells used to treat rats with spinal injury boosted the therapy and motor activity.

Overweight kids at greater risk of school absenteeism

In the first study of how weight may affect school attendance, researchers at the University of Pennsylvania and Temple University have found that overweight children are at greater risk of school absenteeism than their normal-weight peers.

AstraZeneca ChAdOx1 nCoV-19 vaccine does not affect fertility and birth rate outcomes, study says

Researchers from the University of Oxford have recently analyzed pregnancies that have occurred during four ChAdOx1 nCoV-19 clinical trials.

Read more Medical News

› Verified 3 days ago

Provider NameCrystal Vision Consultants Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1184133498
PECOS PAC ID: 1052677424
Enrollment ID: O20171117002335

News Archive

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.

ORT remains underutilized in U.S. prison systems

Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).

Modified stroke drug boosts injury repair in rats with spinal cord damage

Adding a modified stroke drug to stem cells used to treat rats with spinal injury boosted the therapy and motor activity.

Overweight kids at greater risk of school absenteeism

In the first study of how weight may affect school attendance, researchers at the University of Pennsylvania and Temple University have found that overweight children are at greater risk of school absenteeism than their normal-weight peers.

AstraZeneca ChAdOx1 nCoV-19 vaccine does not affect fertility and birth rate outcomes, study says

Researchers from the University of Oxford have recently analyzed pregnancies that have occurred during four ChAdOx1 nCoV-19 clinical trials.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rachel Toth is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Rachel Toth, OD
4151 Baldwin Rd,
Auburn Hills, MI 48326-1225

Ph: () -
Rachel Toth, OD
4151 Baldwin Rd,
Auburn Hills, MI 48326-1225

Ph: (248) 858-2223

News Archive

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.

ORT remains underutilized in U.S. prison systems

Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).

Modified stroke drug boosts injury repair in rats with spinal cord damage

Adding a modified stroke drug to stem cells used to treat rats with spinal injury boosted the therapy and motor activity.

Overweight kids at greater risk of school absenteeism

In the first study of how weight may affect school attendance, researchers at the University of Pennsylvania and Temple University have found that overweight children are at greater risk of school absenteeism than their normal-weight peers.

AstraZeneca ChAdOx1 nCoV-19 vaccine does not affect fertility and birth rate outcomes, study says

Researchers from the University of Oxford have recently analyzed pregnancies that have occurred during four ChAdOx1 nCoV-19 clinical trials.

Read more News

› Verified 3 days ago


Optometrist in Auburn Hills, MI

Leenu Jacob, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 2061 N Squirrel Rd Unit 1976, Auburn Hills, MI 48326
Phone: 248-243-3710    Fax: 248-282-1756
Dr. Michael Joseph Sistick, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 4288 Baldwin Rd, Auburn Hills, MI 48326
Phone: 248-253-0900    Fax: 248-332-4952
Dr. Kenneth Vernon Grattan, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 400 Brown Rd, Auburn Hills, MI 48326
Phone: 248-648-0003    
Svs Vision Inc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 2061 N Squirrel Rd Unit 1976, Auburn Hills, MI 48326
Phone: 248-243-3710    Fax: 248-282-1756
Dr. Dawn Walsh, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 4288 Baldwin Rd, Auburn Hills, MI 48326
Phone: 248-253-0900    Fax: 248-332-4952
Brigid Roney, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 4350 Joslyn Rd, Auburn Hills, MI 48326
Phone: 248-391-0508    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.